Clinical trial
Statins for Treatment Of Primary IntraCerebral Hemorrhage (STOP ICH)
NCT07088250 is registered in ClinicalTrials.gov with The Second Hospital of Anhui Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Statins for Treatment Of Primary IntraCerebral Hemorrhage (STOP ICH)
- Lead sponsor
- The Second Hospital of Anhui Medical University
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- May 6, 2023
- Completion date
- December 31, 2026
- Enrollment
- 264 (estimated)
- Sites
- 22
Conditions
As the registry lists them; a condition with its own page is linked.
cerebrovascular disorders, intracerebral haemorrhage, intracranial hemorrhage, intracranial hemorrhages